Literature DB >> 20346571

Allostery in a monomeric protein: the case of human serum albumin.

Paolo Ascenzi1, Mauro Fasano.   

Abstract

Human serum albumin (HSA), the most prominent protein in plasma, binds different classes of ligands at multiple sites. The globular domain structural organization of monomeric HSA is at the root of its allosteric properties which are reminiscent of those of multimeric proteins. Here, both functional and structural aspects of the allosteric modulation of heme and drug (e.g., warfarin and ibuprofen) binding to HSA and of the drug-dependent reactivity of HSA-heme are reviewed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20346571     DOI: 10.1016/j.bpc.2010.03.001

Source DB:  PubMed          Journal:  Biophys Chem        ISSN: 0301-4622            Impact factor:   2.352


  37 in total

1.  Allosteric effects of gold nanoparticles on human serum albumin.

Authors:  Qing Shao; Carol K Hall
Journal:  Nanoscale       Date:  2016-12-07       Impact factor: 7.790

2.  Characterization of the antigen specificity of T-cell clones from piperacillin-hypersensitive patients with cystic fibrosis.

Authors:  Sabah El-Ghaiesh; Manal M Monshi; Paul Whitaker; Rosalind Jenkins; Xiaoli Meng; John Farrell; Ayman Elsheikh; Daniel Peckham; Neil French; Munir Pirmohamed; B Kevin Park; Dean J Naisbitt
Journal:  J Pharmacol Exp Ther       Date:  2012-02-27       Impact factor: 4.030

3.  Anisotropic energy flow and allosteric ligand binding in albumin.

Authors:  Guifeng Li; Donny Magana; R Brian Dyer
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

4.  Isoniazid and rifampicin inhibit allosterically heme binding to albumin and peroxynitrite isomerization by heme-albumin.

Authors:  Paolo Ascenzi; Alessandro Bolli; Alessandra di Masi; Grazia R Tundo; Gabriella Fanali; Massimo Coletta; Mauro Fasano
Journal:  J Biol Inorg Chem       Date:  2010-09-25       Impact factor: 3.358

5.  Immuno-spin trapping of heme-induced protein radicals: Implications for heme oxygenase-1 induction and heme degradation.

Authors:  Ashutosh Kumar; Douglas Ganini; Leesa J Deterding; Marilyn Ehrenshaft; Saurabh Chatterjee; Ronald P Mason
Journal:  Free Radic Biol Med       Date:  2013-04-25       Impact factor: 7.376

Review 6.  Overview of Albumin and Its Purification Methods.

Authors:  Ramin Raoufinia; Ali Mota; Neda Keyhanvar; Fatemeh Safari; Sara Shamekhi; Jalal Abdolalizadeh
Journal:  Adv Pharm Bull       Date:  2016-12-22

Review 7.  The thiol pool in human plasma: the central contribution of albumin to redox processes.

Authors:  Lucía Turell; Rafael Radi; Beatriz Alvarez
Journal:  Free Radic Biol Med       Date:  2013-06-07       Impact factor: 7.376

8.  Effect of a Synthesized Amyl-Glycine1, 10-Phenanthroline Platinum Nitrate on Structure and Stability of Human Blood Carrier Protein, Albumin: Spectroscopic and Modeling Approaches.

Authors:  Zahra Shafaei; Omid Abazari; Adeleh Divsalar; Behafarid Ghalandari; Atefeh Poursoleiman; Ali Akbar Saboury; Faizan Ahmad
Journal:  J Fluoresc       Date:  2017-05-29       Impact factor: 2.217

9.  Exploration of possible binding sites of nanoparticles on protein by cross-linking chemistry coupled with mass spectrometry.

Authors:  Ni Li; Shang Zeng; Le He; Wenwan Zhong
Journal:  Anal Chem       Date:  2011-08-29       Impact factor: 6.986

10.  The effect of CYP2C9, VKORC1 and CYP4F2 polymorphism and of clinical factors on warfarin dosage during initiation and long-term treatment after heart valve surgery.

Authors:  Vacis Tatarunas; Vaiva Lesauskaite; Audrone Veikutiene; Pranas Grybauskas; Povilas Jakuska; Laima Jankauskiene; Ruta Bartuseviciute; Rimantas Benetis
Journal:  J Thromb Thrombolysis       Date:  2014       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.